Anti-CP26B/ CYP26B1/ CYP26A2 functional antibody

Anti-CP26B/ CYP26B1/ CYP26A2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CYP26B1/CYP26B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1395-Ab-1/ GM-Tg-hg-SE1395-Ab-2Anti-Human CYP26B1 monoclonal antibodyHuman
GM-Tg-rg-SE1395-Ab-1/ GM-Tg-rg-SE1395-Ab-2Anti-Rat CYP26B1 monoclonal antibodyRat
GM-Tg-mg-SE1395-Ab-1/ GM-Tg-mg-SE1395-Ab-2Anti-Mouse CYP26B1 monoclonal antibodyMouse
GM-Tg-cynog-SE1395-Ab-1/ GM-Tg-cynog-SE1395-Ab-2Anti-Cynomolgus/ Rhesus macaque CYP26B1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1395-Ab-1/ GM-Tg-felg-SE1395-Ab-2Anti-Feline CYP26B1 monoclonal antibodyFeline
GM-Tg-cang-SE1395-Ab-1/ GM-Tg-cang-SE1395-Ab-2Anti-Canine CYP26B1 monoclonal antibodyCanine
GM-Tg-bovg-SE1395-Ab-1/ GM-Tg-bovg-SE1395-Ab-2Anti-Bovine CYP26B1 monoclonal antibodyBovine
GM-Tg-equg-SE1395-Ab-1/ GM-Tg-equg-SE1395-Ab-2Anti-Equine CYP26B1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1395-Ab-1/ GM-Tg-hg-SE1395-Ab-2; GM-Tg-rg-SE1395-Ab-1/ GM-Tg-rg-SE1395-Ab-2;
GM-Tg-mg-SE1395-Ab-1/ GM-Tg-mg-SE1395-Ab-2; GM-Tg-cynog-SE1395-Ab-1/ GM-Tg-cynog-SE1395-Ab-2;
GM-Tg-felg-SE1395-Ab-1/ GM-Tg-felg-SE1395-Ab-2; GM-Tg-cang-SE1395-Ab-1/ GM-Tg-cang-SE1395-Ab-2;
GM-Tg-bovg-SE1395-Ab-1/ GM-Tg-bovg-SE1395-Ab-2; GM-Tg-equg-SE1395-Ab-1/ GM-Tg-equg-SE1395-Ab-2
Products NameAnti-CYP26B1 monoclonal antibody
Formatmab
Target NameCYP26B1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CYP26B1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1395-Ag-1Recombinant multi-species CP26B/ CYP26B1/ CYP26A2 protein
    ORF Viral VectorpGMLPm003161mouse Cyp26b1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003161mouse Cyp26b1 Lentivirus particle


    Target information

    Target IDGM-SE1395
    Target NameCYP26B1
    Gene ID56603,232174,312495,704750,483120,101100712,540868,100059609
    Gene Symbol and SynonymsCP26,CYP26A2,CYP26B1,P450RAI-2,P450RAI2,RHFCA
    Uniprot AccessionQ9NR63,G3V7X8,E1BHJ4
    Uniprot Entry NameCP26B_HUMAN,CP26B_RAT,CP26B_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000003137
    Target ClassificationN/A

    The target: CYP26B1, gene name: CYP26B1, also named as CYP26A2, P450RAI-2, P450RAI2, RHFCA. This gene encodes a member of the cytochrome P450 superfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein is localized to the endoplasmic reticulum, and functions as a critical regulator of all-trans retinoic acid levels by the specific inactivation of all-trans retinoic acid to hydroxylated forms. Mutations in this gene are associated with radiohumeral fusions and other skeletal and craniofacial anomalies, and increased levels of the encoded protein are associated with atherosclerotic lesions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.